SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan
· Delayed Price · Currency is TWD 57.70
+0.60 (1.05%)
May 13, 2025, 12:58 PM CST
SunWay Biotech Co., LTD. Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 118.57 | 46.09 | 30.04 | 168.76 | 125.71 | Upgrade
|
| Depreciation & Amortization | 82.46 | 23.67 | 6.4 | 19.62 | 20.09 | Upgrade
|
| Other Amortization | 1.13 | 1.24 | 1.36 | 0.11 | 0.25 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.14 | 0.11 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.04 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.29 | 0.23 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.62 | -0.36 | 0.45 | - | Upgrade
|
| Other Operating Activities | 1.93 | -1.62 | 6.74 | 1.45 | -0.02 | Upgrade
|
| Change in Accounts Receivable | -65.59 | 5.23 | -43.72 | -56.92 | -1.99 | Upgrade
|
| Change in Inventory | -39.81 | 9.91 | -5.97 | 13.11 | 15.03 | Upgrade
|
| Change in Accounts Payable | 26.16 | -36.25 | 33.64 | -0.63 | -0.54 | Upgrade
|
| Change in Unearned Revenue | -2.24 | 0.28 | 6.75 | -3.11 | 0.55 | Upgrade
|
| Change in Other Net Operating Assets | 34.27 | 6.81 | 7.71 | 17.5 | 22.44 | Upgrade
|
| Operating Cash Flow | 156.92 | 55.98 | 42.58 | 160.76 | 181.86 | Upgrade
|
| Operating Cash Flow Growth | 180.30% | 31.47% | -73.51% | -11.60% | 140.68% | Upgrade
|
| Capital Expenditures | -116.19 | -46.24 | - | -9.71 | -1.56 | Upgrade
|
| Cash Acquisitions | - | 293.22 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -7.49 | - | -1.52 | -0.09 | -0.15 | Upgrade
|
| Investment in Securities | -1.39 | - | - | - | - | Upgrade
|
| Other Investing Activities | -0.73 | -28.21 | -1.96 | -1.06 | -0.51 | Upgrade
|
| Investing Cash Flow | -125.8 | 218.78 | -3.48 | -10.86 | -2.21 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 50 | - | Upgrade
|
| Total Debt Issued | - | - | - | 50 | - | Upgrade
|
| Short-Term Debt Repaid | -7.51 | -58.06 | -52.51 | -50 | - | Upgrade
|
| Long-Term Debt Repaid | -32.64 | -11.25 | -1.38 | -9.88 | -9.29 | Upgrade
|
| Total Debt Repaid | -40.15 | -69.31 | -53.9 | -59.88 | -9.29 | Upgrade
|
| Net Debt Issued (Repaid) | -40.15 | -69.31 | -53.9 | -9.88 | -9.29 | Upgrade
|
| Issuance of Common Stock | - | 76.5 | 70 | 4.2 | 57.15 | Upgrade
|
| Repurchase of Common Stock | - | - | -15 | - | - | Upgrade
|
| Common Dividends Paid | -59.39 | -42.65 | -6.44 | -92.73 | - | Upgrade
|
| Other Financing Activities | -0.26 | - | - | - | 2.45 | Upgrade
|
| Financing Cash Flow | -99.8 | -35.46 | -5.33 | -98.4 | 50.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.19 | -0.68 | - | -0.4 | 0.03 | Upgrade
|
| Net Cash Flow | -68.49 | 238.62 | 33.77 | 51.1 | 230 | Upgrade
|
| Free Cash Flow | 40.73 | 9.75 | 42.58 | 151.05 | 180.3 | Upgrade
|
| Free Cash Flow Growth | 317.89% | -77.11% | -71.81% | -16.22% | 141.43% | Upgrade
|
| Free Cash Flow Margin | 4.20% | 1.71% | 10.01% | 39.70% | 57.34% | Upgrade
|
| Free Cash Flow Per Share | 0.67 | 0.32 | 2.11 | 4.40 | 5.55 | Upgrade
|
| Cash Interest Paid | 5.54 | 2.09 | 1.32 | 0.09 | 0.2 | Upgrade
|
| Cash Income Tax Paid | 21.52 | 11.76 | 2.88 | - | - | Upgrade
|
| Levered Free Cash Flow | 5.4 | -78.44 | -43.77 | 85.6 | 132.9 | Upgrade
|
| Unlevered Free Cash Flow | 8.87 | -77.13 | -43.05 | 85.66 | 133.03 | Upgrade
|
| Change in Net Working Capital | 39.16 | 88.36 | 73.8 | 29.12 | -35.5 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.